Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|April 26, 2017
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)Cornelia von Hagens, Ingeborg Walter-Sack, Maren Goeckenjan, et al.
Circulation|September 6, 2006
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarctionPatrick Most, Hanna Seifert, Erhe Gao, et al.
The Journal of Biological Chemistry|May 2, 2003
The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibersPatrick Most, Andrew Remppis, Cornelia Weber, et al.
Circulation|May 2, 2007
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescueSven T Pleger, Patrick Most, Matthieu Boucher, et al.
The Journal of Clinical Investigation|December 4, 2004
Cardiac adenoviral S100A1 gene delivery rescues failing myocardiumPatrick Most, Sven T Pleger, Mirko Völkers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
S100A1 gene therapy preserves in vivo cardiac function after myocardial infarctionSven T Pleger, Andrew Remppis, Beatrix Heidt, et al.
European Heart Journal. Imaging Methods and Practice|October 15, 2024
Awareness of strengths and weaknesses of cardiovascular magnetic resonance imaging: results from a questionnaire surveyVictoria Zieschang, Rebecca Elisabeth Beyer, Maximilian Leo Müller, et al.
European Heart Journal|February 14, 2008
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failureMartin M Borggrefe, Thomas Lawo, Christian Butter, et al.
European Journal of Heart Failure|October 1, 2009
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosisArnt V Kristen, Falk-Udo Sack, Stefan O Schonland, et al.
The Journal of Biological Chemistry|June 5, 2003
Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performancePatrick Most, Andrew Remppis, Sven T Pleger, et al.
Pageof 10